Adenine Sulfate Improves Cardiac Function and the Cardiac Cholinergic System After Myocardial Infarction in Rats

  • Sun Lei
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Lu Jun
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Yu Xiao-Jiang
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Li Dong-Ling
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Xu Xiao-Li
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Wang Bing
    Department of Pathology, College of Medicine, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Ren Ke-Yu
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Liu Jian-Kang
    Institute of Mitochondrial Biology & Medicine, School of Life Science and Technology, Xi’an Jiaotong University, China
  • Zang Wei-Jin
    Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China

この論文をさがす

抄録

Recent studies have shown that vagal activation may have an important therapeutic implication for myocardial infarction (MI), but effective strategies remain unexplored. Here, we investigate whether adenine sulfate can preserve cardiac function and the cholinergic system against MI. Rats were treated with adenine sulfate for three weeks after coronary ligation. Cardiac function was assessed by hemodynamics. The muscarinic M2 receptor and cholinesterase-positive nerves were semi-quantified by immunochemical and histochemical staining. The maximal binding capacity (Bmax) of muscarinic receptors, determined by radioligand binding assay, showed that cardiac function was impaired in MI rats. Adenine sulfate reversed MI-induced reduction of mean artery pressure and left ventricular systolic pressure and elevation of left ventricular end-diastolic pressure. Moreover, adenine sulfate also increased nitric oxide (NO) and nitric oxide synthase (NOS) activity. The amelioration was accompanied by a reversal of the infarction-induced reduction of cholinesterase-positive nerves and M2-receptor expression and Bmax in the adenine sulfate high dose group. Meanwhile, adenine sulfate treatment corrected the disorder of cardiac redox state by reduction in maleic dialdehyde and increase in superoxide dismutase. In conclusion, adenine sulfate exerts cardioprotection against MI and ameliorates NO production. Changes in cardiac vagal distribution density and M2-receptor expression raise the possibility that improvement of the cardiac cholinergic system is involved in adenine sulfate–induced cardioprotective effects.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (52)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ